Overcoming erlotinib resistance with STAT3 inhibition in pancreatic cancer

被引：2
|
作者：
Salzberg, Matthew Philip
Merchant, Nipun B.
机构：
[1] Univ Miami, Jackson Mem Hosp, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Med Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibition of STAT3 overcomes gemcitabine resistance in pancreatic cancer cells
    Chen, Chi-Wei
    Wu, Ruiqin
    Meng, Yunxiao
    Zhu, Wenge
    [J]. CANCER RESEARCH, 2017, 77
  • [2] Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
    Wu, Xiaoqing
    Tang, Wenhua
    Marquez, Rebecca T.
    Li, Ke
    Highfill, Chad A.
    He, Fengtian
    Lian, Jiqin
    Lin, Jiayuh
    Fuchs, James R.
    Ji, Min
    Li, Ling
    Xu, Liang
    [J]. ONCOTARGET, 2016, 7 (10) : 11708 - 11723
  • [3] Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition
    Singh, Sunanda
    Gomez, Hector J. J.
    Thakkar, Shreya
    Singh, Samara P. P.
    Parihar, Ashutosh S. S.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [4] Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
    Shi, Lingyi
    Zheng, Hailun
    Hu, Wanle
    Zhou, Bin
    Dai, Xuanxuan
    Zhang, Yi
    Liu, Zhiguo
    Wu, Xiaoping
    Zhao, Chengguang
    Liang, Guang
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 1767 - 1776
  • [5] Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
    Li, Rui
    You, Shuo
    Hu, Zhongliang
    Chen, Zhuo G.
    Sica, Gabriel L.
    Khuri, Fadlo R.
    Curran, Walter J.
    Shin, Dong M.
    Deng, Xingming
    [J]. PLOS ONE, 2013, 8 (09):
  • [6] Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer
    Nagathihalli, Nagaraj S.
    Castellanos, Jason A.
    Lamichhane, Purushottam
    Messaggio, Fanuel
    Shi, Chanjuan
    Dai, Xizi
    Rai, Priyamvada
    Chen, Xi
    VanSaun, Michael N.
    Merchant, Nipun B.
    [J]. CANCER RESEARCH, 2018, 78 (21) : 6235 - 6246
  • [7] Combined MEK and STAT3 inhibition reprograms the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer
    Garrido, Vanessa Tonin
    Datta, Jashodeep
    Dai, Xizi
    Bianchi, Anna
    Silva, Iago De Castro
    Lamichhane, Purushottam
    Mehra, Siddharth
    Singh, Samara P.
    Dosch, Austin R.
    Umland, Oliver
    VanSaun, Michael N. N.
    Hosein, Peter J.
    Nagathihalli, Nagaraj
    Merchant, Nipun
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [8] Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling
    Phi, Ji Hoon
    Choi, Seung-Ah
    Kim, Seung-Ki
    Wang, Kyu-Chang
    Lee, Ji Yeoun
    Kim, Dong Gyu
    [J]. TRANSLATIONAL ONCOLOGY, 2015, 8 (05): : 376 - 386
  • [9] Targeting Cancer Stem Cells With Combined Inhibition of MEK and STAT3 in Pancreatic Cancer
    Roberts, C.
    Vansaun, M.
    Lamichhane, P.
    Messaggio, F.
    Kovacs, K.
    Nagathihalli, N.
    Merchant, N.
    [J]. PANCREAS, 2016, 45 (10) : 1534 - 1535
  • [10] SiRNA mediated inhibition of STAT3 in human pancreatic cancer cell lines
    Glienke, W.
    Hausmann, E.
    Bergmann, L.
    [J]. ONKOLOGIE, 2010, 33 : 24 - 24
12345